BridgeBio Pharma, Inc. (BBIO)
NASDAQ · Healthcare
BridgeBio Pharma, Inc. Shareholder Equity 2019–2025
BridgeBio Pharma, Inc. annual/quarterly shareholder equity history from 2019 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- BridgeBio Pharma, Inc. shareholder equity for the quarter ending December 31, 2025 were -2.09B, a 42.15% increase year-over-year.
- BridgeBio Pharma, Inc. shareholder equity for 2025 were -2.09B, a 42.15% increase from 2024.
- BridgeBio Pharma, Inc. shareholder equity for 2024 were -1.47B, a 8.39% increase from 2023.
- BridgeBio Pharma, Inc. shareholder equity for 2023 were -1.35B, a 7.94% increase from 2022.
- BridgeBio Pharma, Inc. shareholder equity for 2022 were -1.25B.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| BridgeBio Pharma, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-2,087 |
| 2024 | $-1,468 |
| 2023 | $-1,354 |
| 2022 | $-1,255 |
| 2021 | $-870 |
| 2020 | $58 |
| 2019 | $408 |
| BridgeBio Pharma, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $-2,087 |
| 2024-12-31 | $-1,468 |
| 2023-12-31 | $-1,354 |
| 2022-12-31 | $-1,255 |
| 2021-12-31 | $-870 |
| 2020-12-31 | $58 |
| 2019-12-31 | $408 |
BridgeBio Pharma, Inc. Shareholder Equity — FAQ
BridgeBio Pharma, Inc. (BBIO) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BBIO's shareholder equity history?
The chart and table above show BridgeBio Pharma, Inc.'s shareholder equity by year and by quarter, including the growth rate.